U.S. markets closed

Flexion Therapeutics to Present at the Cowen 39th Annual Health Care Conference

BURLINGTON, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will present at the Cowen 39th Annual Health Care Conference in Boston, Massachusetts. Dr. Clayman is scheduled to present at 1:30 p.m. ET on Monday, March 11, 2019. To access the live webcast and subsequent archived recording of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.

About Flexion Therapeutics
Flexion Therapeutics (FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, a type of degenerative arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. For the past two years, Flexion has been named one of the Best Places to Work by the Boston Business Journal, and a Top Place to Work in Massachusetts by The Boston Globe.


Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194